1. ash68th
2. blueboots70
1.blueboots70 06/25/2018
ERYTECH Confirms Strategic Focus of Eryaspase on Solid Tumors and Ceases Development in Acute Lymphoblastic Leukemia
2.blueboots70 05/15/2018
Reports Q1 net loss of €11.7M
3.ash68th 06/04/2018
ERYTECH to Present Pharmacodynamic Data from Phase 2/3 Trial of Eryaspase in ALL at ASCO 2018
4.blueboots70 03/14/2018
Reports FY net loss of €33.53M
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW